SeraCare Life Sciences (SRLS) Posts Q4 GAAP Loss of 4c/Share

SeraCare Life Sciences, Inc. (NASDAQ: SRLS) reported Q4 GAAP loss of ($0.04), which may not compare with the analyst estimate of $0.02. Revenue for the quarter came in at $10.99 million versus the consensus estimate of $10.95 million.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Newton Golf Company (NWTG) Reports Q2 Loss of $0.49
• CaliberCos Inc (CWD) Misses Q2 EPS by 43c; Offers Guidance